Influence of local radiotherapy on penetration of fluconazole into human saliva.
The pharmacokinetics of fluconazole (50 mg, single oral dose) in saliva and plasma were determined for five healthy subjects and five patients who underwent radiotherapy (dose, > 45 Gy over a 6-week period) in the salivary gland area and suffered from oropharyngeal candidiasis. Saliva was collected after electrical stimulation. Fluconazole was measured by liquid chromatography. From healthy volunteers and patients, saliva and plasma were sampled from 0 to 24 h. Although fluconazole penetration kinetics were significantly slowed down in irradiated patients, saliva concentrations of fluconazole were higher than those in the plasma, except at 1 h. In the postdistribution phase, the saliva/plasma concentration ratio was in the range of 1.2 to 1.4, and there was no significant difference between healthy subjects and patients. The saliva concentration of fluconazole was over 1 mg/liter throughout the entire interval 2 to 24 h after drug intake. From these results, the clinical efficacy of fluconazole for oropharyngeal candidiasis is not expected to be less than that in subjects with normal salivary glands, provided that salivary secretion remains.
Oliary
J
J
Departement de Pharmacologie, Hôpital Avicenne, Bobigny, France.
Tod
M
M
Louchahi
K
K
Petitjean
O
O
Frachet
B
B
Le Gros
V
V
Brion
N
N
D000284:Administration, Oral; D000328:Adult; D005260:Female; D015725:Fluconazole / Q000097:blood / Q000493:pharmacokinetics*; D006258:Head and Neck Neoplasms / Q000378:metabolism / Q000532:radiotherapy; D006801:Humans; D008297:Male; D008875:Middle Aged; D012463:Saliva / Q000378:metabolism* / Q000528:radiation effects*; D012469:Salivary Glands / Q000378:metabolism* / Q000528:radiation effects*
D015725:Fluconazole